Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

As the FDA and NIH eschew animal testing, startup raises $40 million for lab-grown organs

Summary by STAT
FDA, NIH push to reduce or replace animal testing expected to spur growth in organoid firms; Dan Huh's Vivodyne announces $40 million investment.

1 Articles

STATSTAT
Center

As the FDA and NIH eschew animal testing, startup raises $40 million for lab-grown organs

FDA, NIH push to reduce or replace animal testing expected to spur growth in organoid firms; Dan Huh's Vivodyne announces $40 million investment.

·Boston, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

STAT broke the news in Boston, United States on Thursday, May 29, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Startups icon

Startups

Animal Testing icon

Animal Testing

iPhone icon

iPhone

Boston, Massachusetts icon

Boston, Massachusetts

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal